Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case
Agranulocytosis is a rare and critical adverse effect of antithyroid drugs (ATD). The occurrence of agranulocytosis in continuous ATD treatment patients is well known; however, a case of ATD agranulocytosis occurring following the discontinuation of methimazole (MMI) treatment is not a usual situati...
Main Authors: | Rıfkı Üçler, Murat Atmaca, Ömer Candar, Murat Alay, Burhan Göy, Erdal Kara, Mahfuz Turan, Yusuf Demir |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2015/974524 |
Similar Items
-
Methimazole-Induced Concomitant Agranulocytosis and Cholestasis in a Young Female
by: Ayokunle T. Abegunde, MD, et al.
Published: (2016-01-01) -
Unusual Synchronous Methimazole-Induced Agranulocytosis and Severe Hepatotoxicity in Patient with Hyperthyroidism: A Case Report and Review of the Literature
by: Jun Yang, et al.
Published: (2015-01-01) -
A Rare Presentation of Transfusional Hemochromatosis: Hypogonadotropic Hypogonadism
by: Rifki Ucler, et al.
Published: (2015-01-01) -
A Case of Methimazole-Induced Acute Pancreatitis with an HLA Allele Causing Antithyroid Drug-Induced Agranulocytosis
by: Goshima, Y., et al.
Published: (2022) -
Effective Preoperative Plasmapheresis Treatment of Severe Hyperthyroidism in a Patient with Giant Toxic Nodular Goiter and Methimazole-Induced Agranulocytosis
by: Katarzyna Barwinek, et al.
Published: (2020-06-01)